ROSULIP

Treatment of hypercholesterolemia: Adults, adolescents and children aged 6 years or over with pure hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia) or mixed dyslipidemia (type IIb) in addition to a diet when the response to diet and other treatments non-pharmacological (exercise, weight loss) is not sufficient. Adults, adolescents and children aged 6 years or over with homozygous familial hypercholesterolaemia, as an adjunct to diet and other lipid-lowering treatments (including LDL apheresis) or when these treatments are not appropriate. -Prevention of cardiovascular events Prevention of major cardiovascular events in patients considered to be at high risk of having a first cardiovascular event (see Pharmacodynamic properties), in addition to the correction of other risk factors